The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients

NCT00001082 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

505

Enrollment

NIH

Sponsor class

Conditions

Cytomegalovirus Infections
HIV Infections

Interventions

DRUG: Levocarnitine
DRUG: Adefovir dipivoxil
DRUG: Adefovir dipivoxil placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)